SBI Healthcare Opportunities Fund Direct Growth
Add To Comparepreviously known as SBI Pharma Dir Gr until
NAV on April 23, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
2,626 cr
Turnover Ratio
32.00%
Expense Ratio
0.95%
Exit Load
0.50%
if redeemed within
Returns
- 1M: 1.54%
- 1Y: 53.28%
- 3M: 6.39%
- 3Y: 18.72%
- 6M: 27.04%
- 5Y: 24.37%